A clinical trial titled "Slowly Digestible Carbohydrates for GLP-1 Secretion" was recorded as completed on November 6, 2026. The study, registered under identifier NCT07572513, is listed with a phase designation of not applicable. This trial relates to glucagon, a compound with approved regulatory status. The trial record indicates the study has reached completed status as of the date provided. No results, outcomes, or efficacy data were included in this update. The record does not specify details about safety findings or clinical benefit at this time. This brief reflects only the status change reported in the trial registry entry. Readers interested in the broader context of this compound can consult the compound overview for additional background information.
Glucagon-Related Trial "Slowly Digestible Carbohydrates for GLP-1 Secretion" Completed
See the full glucagon overview
Source: https://clinicaltrials.gov/study/NCT07572513